Retour
Fourchette du Jour
70,67 €
71,85 €
Fourchette 52 Semaines
57,65 €
89,77 €
Volume
5 974 726
Moyenne 50J / 200J
79,49 €
/
76,90 €
Clôture Précédente
71,65 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 15,5 | 0,3 |
| P/B | 3,1 | 2,9 |
| ROE % | 22,1 | 3,7 |
| Net Margin % | 10,1 | 3,8 |
| Rev Growth 5Y % | 4,1 | 10,0 |
| D/E | 1,0 | 0,2 |
Objectif de Cours des Analystes
Hold
91,70 €
+29.2%
Low: 77,00 €
High: 105,00 €
P/E Prévisionnel
14,1
BPA Prévisionnel
5,07 €
Croissance BPA (est.)
+0,0%
CA Est.
22 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
7,11 €
6,93 € – 7,24 €
|
25 B | 2 |
| FY2028 |
6,23 €
5,80 € – 6,97 €
|
24 B | 7 |
| FY2027 |
5,60 €
5,28 € – 5,74 €
|
23 B | 14 |
Points Clés
Revenue grew 4,07% annually over 5 years — modest growth
ROE of 22,14% indicates high profitability
Generating 1,51B in free cash flow
Capital efficient — spends only 2,34% of revenue on capex
Croissance
Revenue Growth (5Y)
4,07%
Revenue (1Y)4,84%
Earnings (1Y)4,57%
FCF Growth (3Y)-6,26%
Qualité
Return on Equity
22,14%
ROIC10,16%
Net Margin10,10%
Op. Margin13,39%
Sécurité
Debt / Equity
0,96
Current Ratio1,18
Interest Coverage6,14
Valorisation
P/E Ratio
15,52
P/B Ratio3,12
EV/EBITDA13,70
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,84% | Revenue Growth (3Y) | 2,71% |
| Earnings Growth (1Y) | 4,57% | Earnings Growth (3Y) | 15,29% |
| Revenue Growth (5Y) | 4,07% | Earnings Growth (5Y) | -1,87% |
| Profitability | |||
| Revenue (TTM) | 20,63B | Net Income (TTM) | 2,08B |
| ROE | 22,14% | ROA | 5,65% |
| Gross Margin | 39,99% | Operating Margin | 13,39% |
| Net Margin | 10,10% | Free Cash Flow (TTM) | 1,51B |
| ROIC | 10,16% | FCF Growth (3Y) | -6,26% |
| Safety | |||
| Debt / Equity | 0,96 | Current Ratio | 1,18 |
| Interest Coverage | 6,14 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 15,52 | P/B Ratio | 3,12 |
| P/S Ratio | 1,57 | PEG Ratio | 4,13 |
| EV/EBITDA | 13,70 | Dividend Yield | 0,00% |
| Market Cap | 32,34B | Enterprise Value | 37,83B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20,63B | 19,67B | 19,55B | 18,34B | 17,59B |
| Net Income | 2,08B | 1,99B | 1,57B | 1,92B | 2,25B |
| EPS (Diluted) | 4,55 | 4,34 | 3,02 | 4,22 | 4,90 |
| Gross Profit | 8,25B | 8,21B | 7,92B | 7,18B | 7,17B |
| Operating Income | 2,76B | 2,63B | 2,44B | 2,52B | 2,80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 36,91B | 33,09B | 32,45B | 27,54B | 26,31B |
| Total Liabilities | 26,31B | 24,44B | 25,14B | 17,95B | 9,41B |
| Shareholders' Equity | 10,38B | 8,45B | 7,13B | 9,36B | 16,66B |
| Total Debt | 10,00B | 9,38B | 9,86B | 8,64B | 437,00M |
| Cash & Equivalents | 4,51B | 2,89B | 2,50B | 1,45B | 556,00M |
| Current Assets | 10,70B | 9,52B | 9,01B | 7,82B | 6,54B |
| Current Liabilities | 9,11B | 9,55B | 8,98B | 7,19B | 6,76B |